C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.490
+0.010 (0.29%)
Aug 3, 2026, 10:26 AM EDT - Market open
C4 Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $7 | Buy | Maintains | $7 | +100.57% | Jun 22, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $10 | Buy | Reiterates | $10 | +186.53% | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 | Buy | Maintains | $14 | +301.15% | Apr 30, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $7 | Buy | Reiterates | $7 | +100.57% | Feb 27, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +759.60% | Feb 23, 2026 |